Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor

Abstract

Heart failure (HF) is a leading cause of morbidity and mortality in the western world. Although optimal medical care and treatment is widely available, the prognosis of patients with HF is still poor.Toll-like receptors (TLRs) are important compartments of the innate immunity. Current studies have identified TLRs as critical mediators in cardiovascular diseases. In the present study, we investigated the involvement of TLRs and interferon (IFN) regulatory factors (IRFs) in different experimental HF models including viral myocarditis, myocardial ischemia, diabetes mellitus, and cardiac hypertrophy. In addition, we investigated for the first time comprehensive TLR and IRF gene and protein expression under basal conditions in murine and human cardiac tissue. We found that Tlr4, Tlr9 and Irf7 displayed highest gene expression under basal conditions, indicating their significant role in first-line defense in the murine and human heart. Moreover, induction of TLRs and IRFs clearly differs between the various experimental HF models of diverse etiology and the concomitant inflammatory status. In the HF model of acute viral-induced myocarditis, TLR and IRF activation displayed the uppermost gene expression in comparison to the remaining experimental HF models, indicating the highest amount of myocardial inflammation in myocarditis. In detail, Irf7 displayed by far the highest gene expression during acute viral infection. Interestingly, post myocardial infarction TLR and IRF gene expression was almost exclusively increased in the infarct zone after myocardial ischemia (Tlr2, Tlr3, Tlr6, Tlr7, Tlr9, Irf3, Irf7). With one exception, Irf3 showed a decreased gene expression in the remote zone post infarction. Finally, we identified Irf7 as novel cardiovascular stress-inducible factor in the pathologically stressed heart. These findings on TLR and IRF function in the inflamed heart highlight the complexity of inflammatory immune response and raise more interesting questions for future investigation.

Release of Mitochondrial and Nuclear DNA During On-Pump Heart Surgery: Kinetics and Relation to Extracellular Vesicles

“…Innate immunity: Clinical significance of the TLR9 pathway TLR9 is expressed in normal myocardium, in the infarction zone after myocardial ischemia, and in cardiac tissue during heart failure (46). Studies in animals and small patient groups suggest that the cardiac TLR9 pathway may be important for the development and outcome of myocardial infarction.…”

Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules

“…SHENQI compound targeted 688 genes. Among them, interferon regulatory factor 7 (IRF7) is a new strategy for the treatment of obesity and type 2 diabetes [17]. NEDD4Lis a key gene that associated with type 2 diabetes and cardiovascular continuous complications represented by ischemic heart disease (IHD) [18].…”

“…MCM8 is involved in the regulation of DNA synthesis, regulating cell division in S phase, and has been shown to have a significant regulatory relationship with the prognosis and survival of pancreatic cancer [20]. Interferon regulatory factor 7 (IRF7) is identified as a novel cardiovascular stress inducer in pathologically stressed hearts and involved in the etiology of metabolic disorders, which becoming a new strategy for the treatment of obesity and type 2 diabetes [17,34]. CDK7, a putative thiol-related gene, is regulated by glucose in renal cells and exerts oxidative stress, which may become a potential target for the treatment of diabetic nephropathy [19].…”

Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction

“…The spike protein of SARS-CoV-2 might bind to TLR4 to trigger transmembrane stimulation [ [53] , [54] ]. Then, TLR4 activated interferon (IFN)-regulatory factors (IRF3 and IRF7), leading to increased expression of one of the hub genes IFNB1 and further enhancive the secretion of IFN-β [ [55] , [56] ]. It has been proved the increased IFN-β could stimulate STAT1 and finally resulting in myocardial fibrosis [ [57] , [58] ].…”